David Wurzer

David M.
Wurzer currently works at Renetx Bio, Inc., as Non-Executive Director, Polybiotics LLC, as Director, BiologicsMD, Inc., as Director, Natural Polymer Devices, Inc., as Non-Executive Director, NovaTract Surgical, Inc., as Director, Thetis Pharmaceuticals LLC, as Director, Playhouse Theatre Group, Inc., as Director, Intus Biosciences LLC, as Director, Bactana Corp., as Director, Connecticut Innovations, Inc., as Executive VP & Chief Investment Officer from 2015, Iowa Customs, as President, and Enko Chem, Inc., as Chief Financial Officer.
Mr. Wurzer also formerly worked at DUSA Pharmaceuticals, Inc., as Director, DUSA Pharmaceuticals, Inc., as Independent Director from 2011 to 2012, Standard Diversified, Inc., as Independent Director from 2010 to 2020, Summit Therapeutics Ltd., as Independent Non-Executive Director from 2015 to 2019, Emme, Inc. (Connecticut), as Director, Response Genetics, Inc., as Independent Director from 2010 to 2015, LegiTime Technologies, Inc., as Director, Semantify, Inc., as Director, Retail Optimization, Inc., as Director, Cyvek, Inc., as Director, ZetrOZ, Inc., as Director, 454 Life Sciences Corp., as Director in 2007, SmartPay NewCo LLC, as Director, SmartPay Solutions LLC, as Director, My Gene Counsel LLC, as Non-Executive Director, Compass Therapeutics, Inc., as Independent Director in 2023, PNT Data Corp., as Director, biOasis Technologies, Inc., as Lead Independent Director from 2018 to 2024, CuraGen Corp., as Chief Financial Officer, Treasurer & Executive VP from 1997 to 2007, and Value Health, Inc., as Chief Financial Officer, Treasurer & Senior VP in 1997.
Mr. Wurzer received his undergraduate degree in 1980 from the University of Notre Dame.